12 results
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Upper Extremity ... Superficial #Deep #VTE ... #DVT #Hematology ... Management #Anatomy #Anticoagulation
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
and bridging for VTE ... Clotmaster #VTE ... Anticoagulant #Anticoagulation ... #Dabigatran #Apixaban ... #Pharmacology #Hematology
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Lower Extremity ... Superficial #Deep #VTE ... #DVT #Hematology ... Management #Anatomy #Anticoagulation
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
Fibrillation, VTE ... patients 5mg bid Dabigatran ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology ... #Rivaroxaban #Dabigatran
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
body mass index; VTE ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology ... #Oncology
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
, Breast) • Cancer ... of infection in upper ... extremity) Epitrochlear ... Algorithm #Causes #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... thrombosis in cancer ... #Anticoagulation ... #Management #Hematology ... #Oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thrombosis • Upper ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #anticoagulation ... management #DVT #hematology
Risk factor for VTE in cancer patients

Tumor type 

• Very high risk: gastric, pancreas, brain 

•
Risk factor for VTE ... in cancer patients ... High risk: lung, hematologic ... #RiskFactors #VTE ... #cancer #oncology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... Dabigatran has moderate ... #Chemotherapy #Oncology ... #Hematology #Interactions